Skip to main content
Article
The toxic and hematologic effects of interleukin-1 alpha administered in a phase I trial to patients with advanced malignancies.
Journal of Clinical Oncology (1992)
  • J W Smith nd, National Institutes of Health
  • W J Urba, National Institutes of Health
  • B D Curti, National Institutes of Health
  • L J Elwood, National Institutes of Health
  • R G Steis, National Institutes of Health
  • J E Janik, National Institutes of Health
  • W H Sharfman, National Institutes of Health
  • L L Miller, National Institutes of Health
  • R G Fenton, National Institutes of Health
  • K C Conlon, National Institutes of Health
Publication Date
January 7, 1992
DOI
10.1200/JCO.1992.10.7.1141
Citation Information
J W Smith nd, W J Urba, B D Curti, L J Elwood, et al.. "The toxic and hematologic effects of interleukin-1 alpha administered in a phase I trial to patients with advanced malignancies." Journal of Clinical Oncology Vol. 10 Iss. 7 (1992) p. 1141 - 1152
Available at: http://works.bepress.com/walter-urba/50/